Search Results < Yale Cancer Center

Yale Cancer Center

3519 results

News
Yale New Haven Hospital Oncology Nurse Talks About Closer to Free Ride
Here’s why an oncology nurse working at Yale New Haven Hospital for three decades says she rides.
Source: NBC Connecticut
10 Aug 2022
News
Services Widely Differ for Patients With Cancer Who Have Medicaid Coverage
Though number of United States residents insured through Medicaid has increased significantly over previous years, barriers to accessing cancer care still exist at high-quality centers, according to data published in the JAMA Network Open journal.
Source: Targeted Oncology
4 Aug 2022
News
Closer to Free Marshals Make Sure Patients, Riders Cross the Finish Line
Whether you plan to do 10 miles or 100 miles in this year’s Closer to Free Ride to support cancer research and care, there will be a team of people ready to help you make it across the finish line.
Source: NBC Connecticut
3 Aug 2022
News
Roy S. Herbst, MD, PhD, Reviews Ramucirumab Plus Pembrolizumab in ICI-Resistant NSCLC
At 2022 ASCO, Roy S. Herbst, MD, PhD, spoke about the results of a Lung-MAP substudy showing benefit of ramucirumab plus pembrolizumab vs standard of care chemotherapy for patients with advanced non–small cell lung cancer who demonstrated resistance to prior immunotherapy.
Source: CancerNetwork
3 Aug 2022
News
Yale Cancer Center Diversity Enhancement Program in Oncology welcomes first students
The Diversity Enhancement Program in Oncology program offers an eight-week rotation for two underrepresented in medicine (URiM) students or residents, and is designed to provide exposure to hematology/medical oncology as a career, provide faculty-mentored clinical experience in oncology as well as with a corresponding clinical or translational research project. Students also receive co-mentorship from current Medical Oncology-Hematology T32 fellows.
3 Aug 2022
News
Yale doctor: Many cancers are associated with body weight
As rates of obesity rise, aided by the COVID-19 pandemic, the risk of cancer also is increasing, according to Dr. Eric Winer, director of the Yale Cancer Center.
Source: Hartford Courant
3 Aug 2022
News
Yale Doctor: Many Cancers are Associated with Body Weight
As rates of obesity rise, aided by the COVID-19 pandemic, the risk of cancer also is increasing, according to Dr. Eric Winer, director of Yale Cancer Center.
Source: Hartford Courant
3 Aug 2022
News
Lessons From a Lifelong Patient Turned Oncologist
Eric Winer, MD, talks about how growing up with hemophilia helped him connect with patients.
Source: MedPage Today
2 Aug 2022
News
Embracing Allyship in Academic Surgery: How All Surgeons Can Become Effective Champions for Change
As the surgical community continues to work towards greater diversity, equity, and inclusion, the need for buy-in from all surgeons—including those of the White majority—becomes increasingly apparent.
Source: Journal of the American College of Surgeons
1 Aug 2022
News
Noted Oncology Surgeon Kevin Billingsley, MD, MBA, FACS, Uses Life Experiences to Mold His Leadership Philosophy
In this installment of The ASCO Post’s Global Oncology series, Guest Editor Chandrakanth Are, MBBS, MBA, FRCS, FACS, spoke with Kevin Billingsley, MD, MBA, FACS, Chief Medical Officer of the Smilow Cancer Hospital and Yale Cancer Center.
Source: The ASCO Post
29 Jul 2022
News
Translating Personal Tragedy Into the Search for New Cancer Therapeutics
Patricia LoRusso, DO, deals with the complexities of cancer as a medical oncologist and expert in experimental therapeutics at Yale Cancer Center. Her accomplishments in the early evaluation of new anticancer treatments were recognized by the AACR with a prestigious award at its Annual Meeting 2022.
Source: AACR
29 Jul 2022
News
Pre-surgical Immunotherapy Benefits Are Independent of Race in Women With Triple-Negative Breast Cancer
Despite a higher prevalence of triple-negative breast cancer (TNBC) among Black women compared to White women, Black women are underrepresented in TNBC clinical trials, particularly those involving novel immunotherapies. In a study published today in Clinical Cancer Research, researchers at Yale Cancer Center used data from a previous study showing that the combination of durvalumab and neoadjuvant chemotherapy was well tolerated and resulted in high pathologic complete response (pCR) rate in women with non-metastatic TNBC before surgery to recruit another group of racially diverse patients to see if the results were the same. Durvalumab is an immunotherapeutic that targets the PD-1/PD-L1 immune checkpoint pathway.
29 Jul 2022
News
Overcoming the Challenges of Cancer Care
In this video, Eric Winer, MD, president of the American Society of Clinical Oncology (ASCO), outlines current challenges in cancer care and the resources ASCO offers both clinicians and patients. Winer also is the director of Yale Cancer Center and physician-in-chief of Smilow Cancer Network.
Source: MedPage Today
29 Jul 2022
News
Neoadjuvant Immunotherapy Effective Regardless of Race in Triple-negative Breast Cancer
Results of a phase 1/phase 2 study showed similar treatment outcomes among Black and non-Black women who received durvalumab plus chemotherapy prior to surgery for triple-negative breast cancer.
Source: Healio
29 Jul 2022
News
Benefits of Pre-surgical Immunotherapy Were Independent of Race in Patients with Aggressive Breast Cancer
Treatment outcomes were similar between Black and non-Black patients with triple-negative breast cancer who received neoadjuvant durvalumab (Imfinzi) plus chemotherapy, according to phase I/II clinical trial results published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
Source: AACR
29 Jul 2022
News
Neuro-Oncologist Joins Chênevert Family Brain Tumor Center
Mary Barden, MD, joins Yale Cancer Center in the division of Neuro-Oncology as an Assistant Professor of Clinical Neurology (Neuro-Oncology).
29 Jul 2022
News
By Exploiting the DNA Repair System, Yale Scientists Want to Crack Chemotherapy Resistant Brain Cancer
In a new study published in Science, Yale scientists describe an alternative drug to temozolomide that may overcome brain cancer's resistance to chemotherapy.
Source: Endpoints
28 Jul 2022
News
A New Path for Treating Brain Cancer With a Yale-developed Compound
Yale researchers have developed a new class of molecules that target some of the deadliest brain cancers while sparing healthy tissue. The discovery combines innovative synthetic chemistry and cutting-edge mechanistic studies in molecular biology, and offers a potentially powerful new approach to treating drug-resistant glioma tumors.
28 Jul 2022
News
Yale New Haven Gets New Mobile Mammography Unit
Yale New Haven Health has a new mobile mammography unit to celebrate their 35 years of saving lives, and this unit has all the bells and whistles.
Source: Channel 3 News
27 Jul 2022
News
Meriden Cancer Survivor Readies for First Closer to Free Ride
Frank Soltesz is now cancer-free and is ready for his first-ever Closer to Free Ride in September.
Source: NBC Connecticut
27 Jul 2022